| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/24/2004 | US6780406 Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene |
| 08/24/2004 | US6780324 Preparation of sterile stabilized nanodispersions |
| 08/24/2004 | CA2201784C Method and formulation of stimulating nitric oxide synthesis |
| 08/24/2004 | CA2173626C B1k chain of laminin and methods of use |
| 08/24/2004 | CA2096347C A method for stably storing a pharmaceutical |
| 08/24/2004 | CA2061148C Glia activating factor and its production |
| 08/19/2004 | WO2004070057A2 Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long qt syndrome |
| 08/19/2004 | WO2004070054A2 Methods for preventing mitochondrial permeability transition |
| 08/19/2004 | WO2004070041A1 Vectors for expression of toxins |
| 08/19/2004 | WO2004070037A1 Inhibitors of staphylococcus aureus primary sigma factor and uses thereof |
| 08/19/2004 | WO2004070034A2 Oligonucleotides directed against a survivin gene and use thereof |
| 08/19/2004 | WO2004070033A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in the treatment of cancer |
| 08/19/2004 | WO2004070025A2 Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| 08/19/2004 | WO2004070018A2 Vegf-b and pdgf modulation of stem cells |
| 08/19/2004 | WO2004070015A2 Nematode pan and zp receptor-like sequences |
| 08/19/2004 | WO2004070012A2 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | WO2004069993A2 Non-touch zona pellucida microdrilling of a single - cell embryo with a 1.48 um laser beam for introduction of retrovirus |
| 08/19/2004 | WO2004069992A2 Oligomeric compounds for the modulation of ras expression |
| 08/19/2004 | WO2004069871A1 Growth factor complexes and modulation of cell migration and growth |
| 08/19/2004 | WO2004069870A2 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 08/19/2004 | WO2004069867A2 Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy |
| 08/19/2004 | WO2004069866A1 Therapeutic molecules |
| 08/19/2004 | WO2004069864A1 Polypeptides f' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof |
| 08/19/2004 | WO2004069861A1 Peptidic sulfonamides |
| 08/19/2004 | WO2004069860A2 Isg15-conjugated proteins |
| 08/19/2004 | WO2004069858A2 Leukocyte stimulating peptides |
| 08/19/2004 | WO2004069857A2 “peptides, compositions and uses thereof” |
| 08/19/2004 | WO2004069298A1 Fgf-2 derived proteins for the preparation of biomaterials or medical devices such as stents |
| 08/19/2004 | WO2004069276A1 Drug for preventing, regulating or treating adhesion |
| 08/19/2004 | WO2004069274A2 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 08/19/2004 | WO2004069272A2 Adjuvant combination for use in the immunization of a mamal comprising il2 and il12 |
| 08/19/2004 | WO2004069271A1 Use of human chorionic gonadotropin in the treatment in the treatment of symptoms caused by endometriosis |
| 08/19/2004 | WO2004069270A1 Immunoregulating compounds and an associated method |
| 08/19/2004 | WO2004069269A1 Method for making a cell more susceptible for a compound by expressing the protein, on which said compound acts, in said cell |
| 08/19/2004 | WO2004069268A1 REGENERATION AND NEOGENESIS OF RETINAL VISUAL CELL WITH Otx2 GENE |
| 08/19/2004 | WO2004069267A1 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 08/19/2004 | WO2004069266A2 Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis |
| 08/19/2004 | WO2004069265A1 Use of tryptophan rich peptides |
| 08/19/2004 | WO2004069264A1 Eph/ephrin mediated modulation of cell adhesion and tumour cell metastasis |
| 08/19/2004 | WO2004069259A1 Remedy for diabetes |
| 08/19/2004 | WO2004069247A1 Topical immunotherapy and compositions for use therein |
| 08/19/2004 | WO2004069223A2 Pharmaceutical compositions comprising immunosuppressants and uses thereof |
| 08/19/2004 | WO2004069201A2 Compounds useful in coating stents to prevent and treat stenosis and restenosis |
| 08/19/2004 | WO2004069200A2 Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases |
| 08/19/2004 | WO2004069194A2 Use of the oxidoreductase ncb50r for diagnosings and treating diabetes |
| 08/19/2004 | WO2004069193A2 Methods and compositions for inhibiting cholesterol uptake |
| 08/19/2004 | WO2004069192A2 Material and method for treating microbial mediated dermatological conditions |
| 08/19/2004 | WO2004069190A2 Combination therapy for treating protein deficiency disorders |
| 08/19/2004 | WO2004069182A2 Active immunization to generate antibodies to soluble a-beta |
| 08/19/2004 | WO2004069178A2 Anti-inflammatory activity from lactic acid bacteria |
| 08/19/2004 | WO2004069176A2 Polymer conjugates of mutated neublastin |
| 08/19/2004 | WO2004069175A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON’S DISEASE AND OTHER α-SYNUCLEINOPATHIES |
| 08/19/2004 | WO2004069173A2 Methods for modulating an inflammatory response |
| 08/19/2004 | WO2004069172A2 Multilineage-inducible cells and uses thereof |
| 08/19/2004 | WO2004069169A2 Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same |
| 08/19/2004 | WO2004069166A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | WO2004069165A2 Methods and compositions for the treatment of gastrointestinal disorders |
| 08/19/2004 | WO2004069152A2 Δ4,5 glycuronidase and uses thereof |
| 08/19/2004 | WO2004069136A2 Mucin-like polypeptides |
| 08/19/2004 | WO2004061408A3 Use of a non-specific inhibitor of the 5ht2b receptor for the treatment of prostate cancer |
| 08/19/2004 | WO2004060390A3 Use of a specific inhibitor of the 5ht2b receptor for the treatment of cancer |
| 08/19/2004 | WO2004058180A3 Intraoral calculus dissolving gel composition |
| 08/19/2004 | WO2004055201A3 Cholesterol 24-hydroxylase (cyp46) as therapeutic target for the treatment of alzheimer's disease |
| 08/19/2004 | WO2004052920A9 Conversion of apoptotic proteins |
| 08/19/2004 | WO2004050702A3 Novel ifngamma-like polypeptides |
| 08/19/2004 | WO2004046196A3 Compositions and methods for treating bacterial infections with protein-dalbavancin complexes |
| 08/19/2004 | WO2004038019A3 Dnazyme cleaving mutant polynucleotides |
| 08/19/2004 | WO2004032716A9 Compounds for modulation of cholesterol transport |
| 08/19/2004 | WO2004029075A3 Peptide nucleic acids having improved uptake and tissue distribution |
| 08/19/2004 | WO2004024076A9 Novel compositions and methods for the treatment of immune related diseases |
| 08/19/2004 | WO2004019912A3 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 08/19/2004 | WO2004007675A3 Neuronal and optic nerve gene expression patterns |
| 08/19/2004 | WO2004006756A3 THERAPIES FOR RENAL FAILURE USING INTERFERON-β |
| 08/19/2004 | WO2004004630A3 Osteoinductive biomaterials |
| 08/19/2004 | WO2003091419A3 Kinases and phosphatases |
| 08/19/2004 | WO2003089607A3 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 08/19/2004 | WO2003077834A3 Central airway administration for systemic delivery of therapeutics |
| 08/19/2004 | WO2003068799A3 Oligomeric molecules and uses thereof |
| 08/19/2004 | WO2003057134A8 Specific binding agents of human angiopoietin-2 |
| 08/19/2004 | WO2003053364A3 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 08/19/2004 | WO2003040320A3 Antisense modulation of human collapsin response mediator protein 2 expression |
| 08/19/2004 | WO2003038123A3 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 08/19/2004 | WO2003037260A3 Methods and compositions for treating parkinson's disease |
| 08/19/2004 | WO2003031575A8 A hybrid fusion protein transcription regulator to induce interferon target gene expression |
| 08/19/2004 | WO2002068601A3 Small peptides capable of modulating the function of cd66 (ceacam) family members |
| 08/19/2004 | US20040163147 Nucleic acid sequences comprising pericentric heterochromatic region of a chromosome and nucleotide sequences which confer disease resistance to plants for use in generation of satellite DNA based artificial chromosomes |
| 08/19/2004 | US20040163140 Biological material |
| 08/19/2004 | US20040163136 SEL-12 related methods |
| 08/19/2004 | US20040162421 Methods and compositions for screening of human Borna disease virus |
| 08/19/2004 | US20040162417 Nucleotide sequences coding metalloenzyme for use in detergents, therapeutic, cosmetics, leather processing, solubilizing or softening agents, foods, meat modifiers, feeds and oil and fat seperating agents |
| 08/19/2004 | US20040162415 growth and activity promotion effects on osteoblasts |
| 08/19/2004 | US20040162412 Stabilized protein preparation and process for its preparation |
| 08/19/2004 | US20040162410 Thrombosis therapy; anticoagulants |
| 08/19/2004 | US20040162353 Alpha-difluoromethylornithine(DFMO) suppresses polyamine levels in the human prostate |
| 08/19/2004 | US20040162261 Double chain compound having an amino group and a carboxyl group in the hydrophilic part; forms a stable bilayer membrane vesicle in water, and a water-soluble drug can be enclosed in the internal phase of the vesicle at high efficiency |
| 08/19/2004 | US20040162257 For inhibiting angiogenesis |
| 08/19/2004 | US20040162254 Antiviral oligonucleotides targeting HSV and CMV |
| 08/19/2004 | US20040162253 Administering pharmacologically acceptable oligonucleotide at least 10 nucleotides in length, wherein the anti-HBV activity of oligonucleotide occurs principally by a non-sequence complementary mode of action |
| 08/19/2004 | US20040162251 Pharmaceutical composition containing decoy and method of using the same |
| 08/19/2004 | US20040162250 Remedy and preventive for diseases caused by NF-kB |